Christine Gretzmeier

Freiburg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Systemic clinical-grade recombinant decorin reduces disease burden and fibrosis in advanced recessive dystrophic epidermolysis bullosa.

Systemic clinical-grade recombinant decorin reduces disease burden and fibrosis in advanced recessive dystrophic epidermolysis bullosa.

Journal: Molecular therapy. Advances

Published: November 25, 2025

Calpain Inhibition Protects against UVB-Induced Degradation of Dermal-Epidermal Junction-Associated Proteins.

Calpain Inhibition Protects against UVB-Induced Degradation of Dermal-Epidermal Junction-Associated Proteins.

Journal: The Journal of investigative dermatology

Published: September 15, 2023

Systemic Collagen VII Replacement Therapy for Advanced Recessive Dystrophic Epidermolysis Bullosa.

Systemic Collagen VII Replacement Therapy for Advanced Recessive Dystrophic Epidermolysis Bullosa.

Journal: The Journal of investigative dermatology

Published: July 13, 2021

Increased abundance of Cbl E3 ligases alters PDGFR signaling in recessive dystrophic epidermolysis bullosa.

Increased abundance of Cbl E3 ligases alters PDGFR signaling in recessive dystrophic epidermolysis bullosa.

Journal: Matrix biology : journal of the International Society for Matrix Biology

Published: April 29, 2021

Pro-inflammatory immunity supports fibrosis advancement in epidermolysis bullosa: intervention with Ang-(1-7).

Pro-inflammatory immunity supports fibrosis advancement in epidermolysis bullosa: intervention with Ang-(1-7).

Journal: EMBO molecular medicine

Published: April 07, 2021

Mouse models for dominant dystrophic epidermolysis bullosa carrying common human point mutations recapitulate the human disease.

Mouse models for dominant dystrophic epidermolysis bullosa carrying common human point mutations recapitulate the human disease.

Journal: Disease models & mechanisms

Published: October 26, 2020

Raft-like lipid microdomains drive autophagy initiation via AMBRA1-ERLIN1 molecular association within MAMs.

Raft-like lipid microdomains drive autophagy initiation via AMBRA1-ERLIN1 molecular association within MAMs.

Journal: Autophagy

Published: October 09, 2020

Proteomic Profiling of Fibroblasts Isolated from Chronic Wounds Identifies Disease-Relevant Signaling Pathways.

Proteomic Profiling of Fibroblasts Isolated from Chronic Wounds Identifies Disease-Relevant Signaling Pathways.

Journal: The Journal of investigative dermatology

Published: November 08, 2019

STAT3 targeting in dystrophic epidermolysis bullosa.

STAT3 targeting in dystrophic epidermolysis bullosa.

Journal: The British journal of dermatology

Published: November 02, 2019

Generation of rabbit polyclonal human and murine collagen VII monospecific antibodies: A useful tool for dystrophic epidermolysis bullosa therapy studies.

Generation of rabbit polyclonal human and murine collagen VII monospecific antibodies: A useful tool for dystrophic epidermolysis bullosa therapy studies.

Journal: Matrix biology plus

Published: September 03, 2019

Pseudomonas aeruginosa lectin LecB impairs keratinocyte fitness by abrogating growth factor signalling.

Pseudomonas aeruginosa lectin LecB impairs keratinocyte fitness by abrogating growth factor signalling.

Journal: Life science alliance

Published: May 10, 2019

Impaired lymphoid extracellular matrix impedes antibacterial immunity in epidermolysis bullosa.

Impaired lymphoid extracellular matrix impedes antibacterial immunity in epidermolysis bullosa.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 07, 2018

Showing 1-12 of 29

Last Updated: 09/26/2026